SEED, co-founded by BeyondSpring with 38% equity share, successfully completed its $30 million Series A-3 financing, alongside U.S. Food and Drug Administration (FDA) clearance of its Investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback